Drug Trial Radar · NCT01306461
Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations
Last checked: Nov 20, 2026Latest source record: Jun 8, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
401
Actual
Start
Mar 2011
Primary completion
Apr 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Santen OyIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of the preservative-free fixed-dose combination of tafluprost and timolol (FDC) to concomitant administration of tafluprost and timolol. This study will enroll patients who have ocular hypertension or glaucoma. The study schedule includes seven visits to the study site and three stages: * washout of 5 days to 4 weeks depending on current glaucoma medication (if any) * 6-month study treatment period * 1-3 weeks post-study period
Conditions
- Ocular Hypertension
- Open-angle Glaucoma
Interventions
Timolol and TafluprostDrug
Preservative-free Timolol eye drops administered twice daily concomitantly with preservative-free Tafluprost eye drops administered once daily Treatment period 6 months
Fixed Dose Combination of tafluprost and timololDrug
Preservative-free Fixed Dose Combination of tafluprost and timolol eye drops administered once daily. For masking purposes also: vehicle for timolol administered twice daily Treatment period 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the average diurnal intra-ocular pressure (IOP) at 6 monthsTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site not named
Debrecen, Hungary
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.